Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Jolly Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-23.58 Million could theoretically repay 0% of its total liabilities (CN¥1.46 Billion) in one year. Check 300181 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Cash flow-to-debt ratio of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. Historical debt coverage capacity for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Check Zhejiang Jolly Pharmaceutical Co Ltd (300181) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Zhejiang Jolly Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Zhejiang Jolly Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Jolly Pharmaceutical Co Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥411.80 Million | CN¥1.47 Billion | ▲ +10.6% |
| 2024 | 0.25x | CN¥297.05 Million | CN¥1.17 Billion | ▼ -25.1% |
| 2023 | 0.34x | CN¥288.46 Million | CN¥853.09 Million | ▼ -6.7% |
| 2022 | 0.36x | CN¥318.59 Million | CN¥879.19 Million | ▲ +10.1% |
| 2021 | 0.33x | CN¥251.80 Million | CN¥765.31 Million | ▼ -11.7% |
| 2020 | 0.37x | CN¥279.69 Million | CN¥750.43 Million | ▲ +85.8% |
| 2019 | 0.20x | CN¥128.94 Million | CN¥642.86 Million | ▲ +86.1% |
| 2018 | 0.11x | CN¥78.28 Million | CN¥726.50 Million | ▲ +996.5% |
| 2017 | 0.01x | CN¥6.51 Million | CN¥662.06 Million | ▼ -90.5% |
| 2016 | 0.10x | CN¥58.30 Million | CN¥566.00 Million | ▼ -56.0% |
| 2015 | 0.23x | CN¥97.13 Million | CN¥414.94 Million | ▲ +429.4% |
| 2014 | 0.04x | CN¥13.70 Million | CN¥309.75 Million | ▼ -74.6% |
| 2013 | 0.17x | CN¥29.50 Million | CN¥169.38 Million | ▼ -9.6% |
| 2012 | 0.19x | CN¥30.51 Million | CN¥158.27 Million | ▲ +125.9% |
| 2011 | 0.09x | CN¥13.65 Million | CN¥159.99 Million | ▼ -81.4% |
| 2010 | 0.46x | CN¥64.78 Million | CN¥141.47 Million | ▲ +37.8% |
| 2009 | 0.33x | CN¥43.89 Million | CN¥132.07 Million | ▲ +39.5% |
| 2008 | 0.24x | CN¥31.16 Million | CN¥130.76 Million | ▲ +58.6% |
| 2007 | 0.15x | CN¥16.05 Million | CN¥106.79 Million | — |